Publication | Open Access

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

Neuro-oncologyNeurological FunctioningGliomaHealth-related QualityMedicineCancer ManagementDepatuxizumab MafodotinPharmacotherapyNeurologyHigh-grade GliomasCancer TreatmentAnti-cancer AgentOncologyRadiation Oncology